GlassScriptPhysician profile
Jose Angelo De Dios
NPI 1124227020
$7,888.27
in general payments reported to CMS, 2019-2025
43 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,066 · 2020: $486 · 2021: $441 · 2022: $799 · 2023: $1,354 · 2024: $1,400 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,962 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,962.37 |
| Education | $133.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,229.18 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $500.61 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Mallinckrodt Hospital Products INC. | $470.90 | 2020-2024 | Acthar |
| Olympus Corporation of The Americas | $449.16 | 2019 | |
| Jazz Pharmaceuticals INC. | $409.30 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.13 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Genzyme Corporation | $281.32 | 2019-2025 | |
| Insmed, INC. | $266.85 | 2019-2025 | Arikayce, Brinsupri |
| Sunovion Pharmaceuticals INC. | $255.75 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $242.68 | 2021-2025 | |
| Inspire Medical Systems, INC. | $239.73 | 2023-2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $237.73 | 2020-2025 | Glassia, Cuvitru |
| Grifols USA, LLC | $192.55 | 2019-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $190.70 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $169.32 | 2019-2025 | Opsynvi, Uptravi |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $161.31 | 2019-2024 | Dupixent |
| Amgen INC. | $146.25 | 2022-2025 | Tezspire |
| Janssen Pharmaceuticals, INC | $124.37 | 2019-2020 | |
| Zoll Respicardia, INC. | $120.93 | 2024-2025 | Remede System |
| Baxter Healthcare | $94.38 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Volara System, Hillrom - Vest System Model 205 Acute Care |
| Axsome Therapeutics, INC. | $84.93 | 2023-2025 | Sunosi |
| Mylan Specialty L.P. | $73.52 | 2019 | |
| Electromed, INC. | $60.65 | 2023-2024 | Smartvest |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Azurity Pharmaceuticals, INC. | $44.52 | 2025 | Alvesco, Horizant |
| Philips North America LLC | $39.82 | 2024 | (O58) Sleep Respiratory Care Und, (Ak6) Vest Therapy |
| Alexion Pharmaceuticals, INC. | $39.68 | 2021-2025 | Ultomiris |
| Merck Sharp & Dohme LLC | $35.40 | 2025 | Winrevair |
| Lilly USA, LLC | $29.65 | 2025 | Zepbound |
| Circassia INC. | $27.76 | 2019 | |
| Verona Pharma, INC. | $27.29 | 2025 | Ohtuvayre |
| Optinose US, INC. | $27.16 | 2024 | |
| Genentech USA, INC. | $24.90 | 2025 | Xolair |
| Shire North American Group INC | $24.65 | 2019 | |
| Pfizer INC. | $21.67 | 2023 | |
| Inogen, INC. | $21.18 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Resmed Corp | $20.90 | 2025 | |
| Mallinckrodt Enterprises LLC | $19.84 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.94 | 2019 | |
| Advanced Respiratory, INC | $18.38 | 2020 | |
| Viatris Specialty LLC | $14.20 | 2025 | Yupelri |
| Itamar Medical INC | $13.53 | 2024 | Watchpatone |
| Pulmonx Corporation | $13.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Angelo De Dios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.